Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine,...
-
Upload
adela-garrison -
Category
Documents
-
view
220 -
download
0
description
Transcript of Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine,...
![Page 1: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/1.jpg)
Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE
Director EchocardiographyProfessor of Medicine, College of Medicine
Mayo Clinic, Scottsdale, Arizona
ASSESSMENT OF CAROTID ATHEROSCLEROSIS IN MY CLINICAL PRACTICE
![Page 2: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/2.jpg)
Carotid Bifurcation US Femoral Bifurcation US
Arterial Segments Commonly Involved in Atherosclerosis
![Page 3: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/3.jpg)
Subclinical Atherosclerosis
Adapated from Naqvi TZ, Lee MS. JACC Cardiovasc Imaging. 2014 Oct;7(10):1025-38
![Page 4: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/4.jpg)
Value in Clinical Practice
![Page 5: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/5.jpg)
53 yr old male T chol: 251HDL 53LDL 167TG 70Framingham risk:11%
Case
![Page 6: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/6.jpg)
61 yr old female Total cholesterol 216HDL 50LDL 143Triglycerides 239 mg/dlFRS 6%
Case
![Page 7: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/7.jpg)
Case: My patient is not compliant..
50 yr old Caucasian female, history of DM, non compliant with diet or lipid lowering agents
![Page 8: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/8.jpg)
![Page 9: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/9.jpg)
Case: 45 year old maleHTN,h/o of RCA stent 3 yrs ago,
-ve stress echoWould not take statins
![Page 10: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/10.jpg)
Case: 45 year old male
HTN,h/o of RCA stent 3 yrs ago, -ve stress
echoWould not take statins
![Page 11: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/11.jpg)
Case: I am Intolerant to Statins and Would not
take’m67 MCABGInf MI, EF 40%Recent LCX Stent
Naqvi TZ. J Am Soc Echocardiogr. 2015 May; 28(5):A16-7
![Page 12: Tasneem Z Naqvi, MD, FRCP (UK), MMM, FACC, FASE Director Echocardiography Professor of Medicine, College of Medicine Mayo Clinic, Scottsdale, Arizona.](https://reader036.fdocuments.net/reader036/viewer/2022062317/5a4d1b657f8b9ab0599afadf/html5/thumbnails/12.jpg)
Summary
CIMT and plaque imaging is feasible in clinical practice in primary prevention setting and can improve CVD risk prediction over conventional methods
CIMT and plaque imaging can detect atherosclerosis burden in secondary prevention setting and improve patient compliance
Common Carotid